Business
With a new deal to collaborate on an inhalable hypertension drug, the executives at Southern California drugmaker MannKind Corp. can breathe a little easier about the company’s finances.
Sept. 4, 2018
Science & Medicine
Los Angeles-based Alpha Therapeutic Corp., a blood products unit of Japan’s Green Cross Corp., agreed to hire an outside consultant and beef up its quality control practices in a consent decree with U.S. regulators to be filed in federal court.
Jan. 28, 1998
VLI Corp. said it has begun the third phase of clinical tests on its therapeutic sponge for treatment of bacterial vaginosis, a vaginal infection that the company says afflicts up to 10 million women a year.
May 28, 1986
MicroProbe to Make Cancer Drugs: MicroProbe Corp. announced the formation of a new unit to develop drugs against certain infectious diseases and cancers.
Sept. 17, 1991
Chiron Corp. is considering seeking a partner for its vaccines business or selling the business outright as the biotech company moves to stem losses from the unit.
Oct. 10, 1998
10 Research Unit Acquired: Neocrin Co., the Irvine biotechnology firm that is developing an artificial pancreas for treating diabetics, has signed an agreement to acquire the diabetes research unit of a New England firm.
Dec. 28, 1993
Irvine biomedical company Cardiac Science Inc. said it sold assets of its diagnostic monitoring unit to Biosensor Corp. of North Carolina.
Jan. 12, 1999
John B.
May 21, 2000
Technology and the Internet
A bankruptcy court has approved the sale of certain assets of CellPro Inc., which filed for bankruptcy after losing a patent infringement lawsuit, to an Irvine subsidiary of Delaware-based VIMRx Pharmaceuticals Inc., the VIMRx unit announced Monday.
Dec. 15, 1998
Bausch & Lomb Inc. agreed to sell its skin-care business to Andrew Jergens Co., a maker of skin-care products, for $135 million and the assumption of certain liabilities.
April 9, 1998